Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Myriad Genetics Stock News

MYGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$5.25

-0.08-1.50%

At close: -

$5.48

0.234.38%

After Hours: 6:04 PM EDT

Myriad Genetics (MYGN) Forecast

News

Earnings Myriad Genetics (MYGN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Myriad Genetics Stock News | NASDAQ:MYGN | Benzinga

Get the latest news on Myriad Genetics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Myriad Genetics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, June 03, 2025

Myriad Genetics shares are trading higher. Th...
Benzinga Newsdesk

Monday, June 02, 2025

Myriad Genetics shares are trading higher aft...
Benzinga Newsdesk
Myriad Genetics Announces MONSTAR-SCREEN 3 Da...
Benzinga Newsdesk

Wednesday, May 21, 2025

This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday
Avi Kapoor
Scotiabank Downgrades Myriad Genetics to Sect...
Benzinga Newsdesk

Monday, May 19, 2025

CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday
Avi Kapoor

Thursday, May 15, 2025

Piper Sandler Maintains Overweight on Myriad ...
Benzinga Newsdesk

Thursday, May 08, 2025

Wells Fargo Downgrades Myriad Genetics to Equ...
Benzinga Newsdesk

Wednesday, May 07, 2025

What Analysts Are Saying About Myriad Genetics Stock
Benzinga Insights
Myriad Genetics Publishes RiskScore Study In ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Goldman Sachs Maintains Buy on Myriad Genetic...
Benzinga Newsdesk
Crude Oil Falls 1%; Uber Sales Miss Estimates
Avi Kapoor
UBS Maintains Neutral on Myriad Genetics, Low...
Benzinga Newsdesk
Raymond James Reiterates Outperform on Myriad...
Benzinga Newsdesk
Myriad Genetics shares are trading lower foll...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tuesday, May 06, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Myriad Genetics shares are trading lower afte...
Benzinga Newsdesk
Myriad Genetics Lowers FY2025 Adj EPS Guidanc...
Benzinga Newsdesk
Myriad Genetics Q1 Adj. EPS $(0.03) Beats $(0...
Benzinga Newsdesk
Earnings Scheduled For May 6, 2025
Benzinga Insights

Monday, May 05, 2025

Myriad Genetics's Earnings: A Preview
Benzinga Insights

Friday, April 25, 2025

Myriad Genetics To Present At AACR Annual Mee...
Benzinga Newsdesk

Monday, April 21, 2025

Myriad Genetics Releases Study Results That S...
Benzinga Newsdesk

Thursday, April 17, 2025

Demystifying Myriad Genetics: Insights From 10 Analyst Reviews
Benzinga Insights
Goldman Sachs Maintains Buy on Myriad Genetic...
Benzinga Newsdesk

Wednesday, April 09, 2025

Guggenheim Downgrades Myriad Genetics to Neut...
Benzinga Newsdesk

Tuesday, April 01, 2025

10 Analysts Assess Myriad Genetics: What You Need To Know
Benzinga Insights
Scotiabank Maintains Sector Outperform on Myr...
Benzinga Newsdesk
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Wednesday, March 12, 2025

Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade
Vandana Singh
This HubSpot Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor
Myriad Genetics shares are trading higher aft...
Benzinga Newsdesk
Piper Sandler Upgrades Myriad Genetics to Ove...
Benzinga Newsdesk

Tuesday, March 04, 2025

Piper Sandler Maintains Neutral on Myriad Gen...
Benzinga Newsdesk

Monday, March 03, 2025

Analyst Expectations For Myriad Genetics's Future
Benzinga Insights
B of A Securities Maintains Underperform on M...
Benzinga Newsdesk

Tuesday, February 25, 2025

Myriad Genetics shares are trading lower foll...
Benzinga Newsdesk
Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEO
Vandana Singh
Raymond James Reiterates Outperform on Myriad...
Benzinga Newsdesk
UBS Maintains Neutral on Myriad Genetics, Low...
Benzinga Newsdesk

Monday, February 24, 2025

Myriad Genetics shares are trading lower afte...
Benzinga Newsdesk
Myriad Genetics Appoints Sam Raha, The Compan...
Benzinga Newsdesk
Myriad Genetics Affirms FY2025 Adj EPS Guidan...
Benzinga Newsdesk
Myriad Genetics Q4 Adj $0.03, Inline, Sales $...
Benzinga Newsdesk
Myriad Genetics Enters Collaboration With PAT...
Benzinga Newsdesk
Earnings Scheduled For February 24, 2025
Benzinga Insights

Thursday, February 13, 2025

Myriad Genetics shares are trading higher on ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved